ArticleHepatic medicine : evidence and research2021

Evaluation of MicroRNA-122 as a Biomarker for Chronic Hepatitis C Infection and as a Predictor for Treatment Response to Direct-Acting Antivirals.

Naglaa S Elabd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.